Seegene Unveils STAgora™, A Cutting-Edge Infectious Disease Analysis Platform

Seegene Unveils STAgora™: A New Era in Infectious Disease Analysis



In a significant advancement for public health, Seegene Inc., a global front-runner in molecular diagnostic solutions, has officially launched its innovative STAgora™ platform. This next-generation system is designed to revolutionize the analysis and management of infectious diseases by providing real-time insights into outbreaks through an amalgamation of diagnostic data and sophisticated statistical modeling.

Enhancing Real-Time Decision Making


STAgora™ serves as an intelligence system, delivering timely data visualization and outbreak trends across municipal, national, and continental levels. With its ability to swiftly analyze results from diagnostic tests, healthcare professionals can now access structured reports alongside statistical analyses that are clear and practical. The platform is equipped with customizable dashboards and real-time alert functions that bolster situational awareness and response capabilities.

The flexibility of STAgora™ allows it to track individual cases while simultaneously monitoring outbreaks in selected regions, both locally and internationally. This feature enhances the capability of health authorities to visualize disease spread in real-time, thus strengthening rapid responses based on data-driven insights. STAgora™ aims to provide national and global health authorities with immediate epidemiological information, promoting informed decision-making and efficient response strategies against large-scale infectious disease outbreaks.

Advanced Analytics for Predictive Insights


Equipped with over 40 integrated statistical tools, STAgora™ facilitates early identification of unusual pathogen patterns while enabling predictive modeling of seasonal trends and emerging outbreaks. Users can analyze symptom-based co-infections and calculate real-time infection rate trends, thereby transforming static data into actionable foresight that guides proactive interventions. Unlike traditional outbreak monitoring systems that rely on retrospective data, STAgora™ conducts real-time analyses based on PCR diagnostics, providing immediate visibility into pathogen spread and employing AI-driven algorithms to predict potential future epidemics.

According to Young-Seag Baeg, Seegene's Chief Strategic Planning Officer, “The distinguishing factor of STAgora™ is its unique architecture, which aggregates real-time diagnostic data from around the globe into a unified analysis platform.” Coupled with Seegene’s exclusive syndromic quantitative PCR technology, STAgora™ provides enhanced visibility into single pathogen infections along with simultaneous multi-pathogen co-infections. This comprehensive diagnostic information enables clinicians to make quicker, more informed decisions directly at the point of care.

Addressing Complex Threats in Public Health


During the COVID-19 pandemic, the necessity for precise and rapid interpretation of diagnostic data became apparent for developing public health policies and enhancing clinical outcomes. Daniel Shin, Seegene's Executive Vice President and Head of Sales and Marketing, remarked, “As we face increasingly complex threats such as antimicrobial resistance, viral mutations, and co-infections, the ability to derive actionable insights from diagnostic data becomes the cornerstone of clinical innovation and a crucial pillar of global health security.”

Seegene will officially present STAgora™ during the 2025 Annual Meeting of the Association for Diagnostics Laboratory Medicine (ADLM) in Chicago, taking place from July 27 to 31. This event will showcase the platform's key capabilities, including its integration with CURECA™, Seegene’s fully automated and operator-free PCR system. The ADLM 2025 will also serve as a pivotal platform for Seegene to explore collaborative and partnership opportunities globally with health sector leaders and clients.

Building a More Connected Global Health Defense


With the introduction of STAgora™, Seegene aims to lay the groundwork for a more intelligent, faster, and interconnected global health defense system. By integrating real-time molecular diagnostics, AI-driven analytics, and worldwide data integration, STAgora™ represents a strategic step towards establishing a smart public health infrastructure capable of proactively addressing emerging threats. The company envisions this platform as an essential cornerstone of the global infectious disease response framework, symbolizing a new chapter in enhancing preparedness and understanding in diagnostics.

About Seegene


Seegene has over 20 years of expertise in research and development, manufacturing, and business management within the realm of real-time syndromic PCR technology. This experience was especially highlighted during the COVID-19 pandemic when Seegene provided over 340 million tests to more than 100 countries worldwide. The key feature of Seegene’s real-time syndromic PCR technology is its ability to simultaneously test for up to 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information.

About CURECA™


CURECA™ (Continuous, Unlimited, Random-access, Expandable, and Customizable Automation) is a fully automated and modular PCR system that eliminates manual processes, allowing for continuous and real-time testing. Designed to work around the clock without human intervention, it features the CPS, the world's first automated pre-treatment system capable of processing a full range of sample types, including blood, stool, sputum, and urine. Ideal for both centralized and decentralized laboratories, CURECA offers scalable automation and flexible adoption, making it particularly useful in environments with limited space and personnel.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.